Vor Biopharma Inc. (VOR)

Vor Biopharma Market Cap

Vor Biopharma has a market cap or net worth of $122.87 million as of May 17, 2024. Its market cap has decreased by -57.22% in one year.

• Market Cap: 122.87M
• Enterprise Value: 47.71M
• 1-Year Change: -57.22%
• Ranking: #3973
• Category: Micro-Cap
• Stock Price: $1.81

Market Cap Chart

Since the IPO on February 5, 2021, Vor Biopharma's market cap has decreased from $635.28M to $122.87M, a decrease of -80.66%. That is a compound annual growth rate of -39.41%.

Market Cap History

Date	Market Cap	% Change
May 17, 2024	123.50M	0.49%
May 16, 2024	122.90M	3.45%
May 15, 2024	118.80M	3.57%
May 14, 2024	114.70M	-1.12%
May 13, 2024	116.00M	-0.60%
May 10, 2024	116.70M	-5.51%
May 9, 2024	123.50M	-2.06%
May 8, 2024	126.10M	5.08%
May 7, 2024	120.00M	0.59%
May 6, 2024	119.30M	-2.77%
May 3, 2024	122.70M	2.25%
May 2, 2024	120.00M	-0.58%
May 1, 2024	120.70M	2.90%
Apr 30, 2024	117.30M	-1.10%
Apr 29, 2024	118.60M	2.95%
Apr 26, 2024	115.20M	-0.60%
Apr 25, 2024	115.90M	-2.28%
Apr 24, 2024	118.60M	-7.49%
Apr 23, 2024	128.20M	3.30%
Apr 22, 2024	124.10M	6.43%
Apr 19, 2024	116.60M	1.83%
Apr 18, 2024	114.50M	-2.88%
Apr 17, 2024	117.90M	1.11%
Apr 16, 2024	116.60M	-4.97%
Apr 15, 2024	122.70M	-5.25%

View and export this data all the way back to 2021. Sign Up Today.

Related Stocks

Company	Market Cap
So-Young International	128.25M
PDS Biotechnology	128.01M
Amylyx Pharmaceuticals	126.15M
FibroGen	125.84M
Coya Therapeutics	124.25M
Allakos	124.01M
VistaGen Therapeutics	122.15M
Cellectar Biosciences	120.99M